WHO Recommends Oxford-Serum Institute Malaria Vaccine: 2023 A Potential Game-Changer in the Fight Against Malaria
In a landmark development, the R21/Matrix-M malaria vaccine, a collaborative effort between the University of Oxford and the Serum Institute of India, with the support of Novavax’s adjuvant technology, has received a strong recommendation from the World Health Organization (WHO). This endorsement comes after rigorous assessments of safety, quality, and effectiveness, marking a significant step … Read more